1-10 of 10
Wendy A. Hudson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EVI1 is critical for the pathogenesis of a subset of MLL-AF9 –rearranged AMLs

Clinical Trials & Observations
Eric M. J. Bindels, Marije Havermans, Sanne Lugthart, Claudia Erpelinck, Elizabeth Wocjtowicz, Andrei V. Krivtsov, Elwin Rombouts, Scott A. Armstrong, Erdogan Taskesen, Jurgen R. Haanstra, H. Berna Beverloo, Hartmut Döhner, Wendy A. Hudson, John H. Kersey, Ruud Delwel, Ashish R. Kumar
Journal: Blood
Blood (2012) 119 (24): 5838–5849.
https://doi.org/10.1182/blood-2011-11-393827
Published: 2012
Includes: Supplemental data
Journal Articles

A role for MEIS1 in MLL -fusion gene leukemia

Brief Report
Ashish R. Kumar, Quanzhi Li, Wendy A. Hudson, Weili Chen, Thien Sam, Qing Yao, Erik A. Lund, Baolin Wu, Branden J. Kowal, John H. Kersey
Journal: Blood
Blood (2009) 113 (8): 1756–1758.
https://doi.org/10.1182/blood-2008-06-163287
Published: 2009
Includes: Supplemental data
Journal Articles

Mll-AF9 Initiates Fetal Hematopoietic Stem Cell Transformation but Development of Overt Leukemia Requires Additional Events in Post-Natal Cells

Weili Chen, Wendy A Hudson, Thien N Sam, John H. Kersey, MD
Journal: Blood
Blood (2008) 112 (11): 2840.
https://doi.org/10.1182/blood.V112.11.2840.2840
Published: 2008
Journal Articles

Evi1 Promotes Leukemogenesis by Anti-Apoptotic Rather Than Differentiation-Blocking Effects in Murine MLL-AF9 Leukemia

Ashish Kumar, MBBS, PhD, Quanzhi Li, PhD, Wendy A Hudson, Thien N Sam, Weili Chen, John H Kersey, MD
Journal: Blood
Blood (2008) 112 (11): 593.
https://doi.org/10.1182/blood.V112.11.593.593
Published: 2008
Journal Articles

MEIS1 Is a Promising New Target for Leukemia Therapy.

Ashish Kumar, MD, PhD, Quanzhi Li, PhD, Weili Chen, Wendy A. Hudson, John H. Kersey, MD
Journal: Blood
Blood (2007) 110 (11): 872.
https://doi.org/10.1182/blood.V110.11.872.872
Published: 2007
Journal Articles

The Mll-AF9 Knock-In Fusion Gene Results in Reprogramming and Enhanced Self-Renewal of Hematopoietic Progenitors, Especially in the HSC and CLP Populations.

Weili Chen, Ashish R. Kumar, Wendy A. Hudson, Quanzhi Li, John H. Kersey
Journal: Blood
Blood (2006) 108 (11): 1421.
https://doi.org/10.1182/blood.V108.11.1421.1421
Published: 2006
Journal Articles

Differential Expression of Mll-AF9 Up-Regulated Genes Correlates with Enhanced Self-Renewal of Hematopoietic Progenitors.

Ashish R. Kumar, MD, PhD, Wendy A. Hudson, Weili Chen, Rodney A. Staggs, Anne-Francoise Lamblin, PhD, John H. Kersey, MD
Journal: Blood
Blood (2006) 108 (11): 733.
https://doi.org/10.1182/blood.V108.11.733.733
Published: 2006
Journal Articles

A Screen for Mll-AF9 Cooperating Mutations in Leukemogenesis Using MLV-Based Mutagenesis.

Rachel J.S. Bergerson, Lara S. Collier, PhD, Tony Cox, PhD, Wendy A. Hudson, Raha Allaei, Linda Wolff, PhD, John H. Kersey, MD, David J. Adams, PhD, David A. Largaespada, PhD
Journal: Blood
Blood (2006) 108 (11): 1417.
https://doi.org/10.1182/blood.V108.11.1417.1417
Published: 2006
Journal Articles

A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy

Weili Chen, Quanzhi Li, Wendy A. Hudson, Ashish Kumar, Nicole Kirchhof, John H. Kersey
Journal: Blood
Blood (2006) 108 (2): 669–677.
https://doi.org/10.1182/blood-2005-08-3498
Published: 2006
Includes: Supplemental data
Journal Articles

Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia

Ashish R. Kumar, Wendy A. Hudson, Weili Chen, Ritsuo Nishiuchi, Qing Yao, John H. Kersey
Journal: Blood
Blood (2004) 103 (5): 1823–1828.
https://doi.org/10.1182/blood-2003-07-2582
Published: 2004
Includes: Supplemental data